Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia

Avibactam is a non-β-lactam β-lactamase inhibitor that has been approved in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and nosocomial pneumonia, including ventilator-associated pneumonia. In Europe, ceftazidime-avib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Das, Shampa, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J., Newell, Paul, Melnick, David, Critchley, Ian A., Stone, Gregory G., Nichols, Wright W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2019
Assuntos:
Minireview
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437548/
https://ncbi.nlm.nih.gov/pubmed/30670413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02187-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados